FBXW7 and cancer: It is, therefore, not surprising that loss-of-function of FBXW7 by genomic deletion or mutation, promoter hypermethylation frequently occurs in various human cancers (Welcker and Clurman, 2008; Nakayama and Nakayama, 2006; Wang et al., 2014).